Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPediatrics/NeonatologyCurative BPD Coverage Policy Update | OpenPayer
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    ModifiedCurativePolicy CHP-IP-2026-090

    Bronchopulmonary Dysplasia

    Customize your policy alerts

    Sign up for curative Policy CHP-IP-2026-090 alerts

    Get alerted when Policy CHP-IP-2026-090 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Medical necessity for continued NICU or special care nursery stays, level of care, discharge readiness, and readmission for respiratory decompensation in neonates and young infants with evolving or established bronchopulmonary dysplasia.

    Policy Summary
    PayerCurative
    PolicyBronchopulmonary Dysplasia
    Policy CodePolicy CHP-IP-2026-090
    Change TypeModified
    Effective DateN/A
    Next Review DateN/A
    Key ActionDocument respiratory support mode and flow at 36 weeks PMA and the resulting BPD grade.
    SourceLink
    POLICY UPDATE CHANGES

    The policy replaces the former oxygen-based BPD severity scheme with the Jensen 2019 respiratory-support grades at 36 weeks postmenstrual age.

    BPD is changed from an admission diagnosis to criteria focused on continued stay and discharge readiness.

    The policy adds pathways for BPD-associated pulmonary hypertension and tracheostomy with chronic home ventilation.

    Stable low-flow oxygen alone does not justify continued inpatient care when discharge readiness criteria are met and home oxygen is arranged.

    3Jensen BPD grades
    ALL 10Discharge criteria
    24–72 hoursConcurrent review
    5–7 daysEvent-free observation
    0.20FiO2 red flag

    Medical Necessity and Level-of-Care Criteria

    Inpatient admission

    Covered when BOTH a clinical severity finding and a hospital-level service are present.

    • Clinical severity finding

      • Preterm infant with support: Born below 32 weeks and requiring positive-pressure respiratory support or supplemental oxygen at 28 days of age or older, or at 36 weeks PMABPD grade 1 to 3
      • Grade 2 or 3 support: High-flow nasal cannula above 2 L/min, noninvasive positive pressure, or invasive ventilation
      • Acute decompensation: Rising FiO2, hypercapnia with respiratory acidosis, or increased work of breathing requiring escalation of support
    Policy Summary
    PayerCurative
    PolicyBronchopulmonary Dysplasia
    Policy CodePolicy CHP-IP-2026-090
    Change TypeModified
    Effective DateN/A
    Next Review DateN/A
    Key ActionDocument respiratory support mode and flow at 36 weeks PMA and the resulting BPD grade.
    SourceLink
    On This Page
    Medical Necessity and Level-of-Care CriteriaDiagnostic, Procedural, and Operational CodingAuthorization and Documentation RequirementsPolicy BackgroundClinical Definitions
    FiO2 increase of 0.20 or more
  1. Pulmonary hypertension: BPD-associated pulmonary hypertension documented on echocardiography
  2. Hospital-level service

    • Positive-pressure support: CPAP, noninvasive ventilation, high-flow nasal cannula, or invasive ventilation
    • Oxygen titration: Supplemental oxygen requiring frequent titration to the target saturation range
    • Systemic corticosteroid course: Low-dose dexamethasone or hydrocortisone after shared decision-making with parents
    • Pulmonary vasodilator management: Pulmonary vasodilator initiation or titration with echocardiographic monitoring
    • Tracheostomy and chronic ventilation: Tracheostomy placement and initiation of chronic home ventilation with caregiver training
  3. Observation or outpatient instead of inpatient

    Discharge home is appropriate when the infant has stable grade 1 BPD, consistent saturations, home oxygen arranged, and trained caregivers.

    Stable grade 1 discharge: Stable grade 1 BPD on low-flow oxygen with consistent saturations, arranged home oxygen, and trained caregivers

    Outpatient pulmonology follow-up is required.

    Level of care: intensive care unit

    NICU AAP Level III or IV intensive care is appropriate when ANY criterion is present.

    Intensive-care level

    • Initial intensive phase: Gestational age below 32 0/7 weeks or birth weight below 1500 g during initial stabilization and intensive phase

      AAP Level III population.

    • Advanced respiratory support: Invasive mechanical ventilation beyond brief stabilization, high-frequency ventilation, or inhaled nitric oxide
    • Hemodynamic support: Vasoactive or inotropic infusion, or volume resuscitation for hypotension or poor perfusion
    • Critical procedures or monitoring: Therapeutic hypothermia, ECMO, exchange transfusion, or continuous arterial blood pressure monitoring through an umbilical or peripheral arterial line
    • On-site surgical or cardiac care: Surgical or interventional condition requiring pediatric surgical or cardiac subspecialty care on site, including preoperative and postoperative periods

      AAP Level IV.

    • Severe BPD or crisis: Grade 3 BPD on invasive ventilation or BPD with pulmonary hypertensive crisis

    Level of care: step-down or intermediate care

    Special care nursery AAP Level II or NICU intermediate/continuing care is appropriate when intensive-care criteria are not met and ANY criterion is present.

    Intermediate-care level

    • Physiologic immaturity or moderate illness: Gestational age 32 0/7 weeks or more and birth weight 1500 g or more with apnea of prematurity, inability to maintain temperature, inability to take all feeds orally, or moderate illness expected to resolve rapidly

      AAP Level II.

    • Noninvasive or brief ventilatory support: Nasal CPAP, high-flow nasal cannula, or mechanical ventilation of brief duration while stabilizing or awaiting transferMechanical ventilation under 24 hours
    • Basic nutritional support: Gavage feeding, intravenous fluids, or parenteral nutrition through peripheral access in an otherwise stable infant
    • Convalescent care: Back-transfer from a Level III or IV unit for growth, feeding, and event monitoring
    • BPD weaning or low-flow oxygen: Grade 1 or 2 BPD weaning from noninvasive support or on low-flow oxygen with ongoing titration while growing and feeding

    Level of care: medical-surgical unit

    Medical-surgical equivalent care is appropriate when ANY criterion applies and no intensive or intermediate criterion is met.

    Medical-surgical or Level I care

    • Stable term or late-preterm infant: Gestational age 35 0/7 weeks or more, normal temperature in an open crib, breathing room air, and feeding orally

      AAP Level I well newborn or mother-baby care.

    • Other low-acuity need: Routine observation after reassuring sepsis risk assessment or phototherapy below exchange thresholds in a well infant

    Discharge readiness

    Discharge is appropriate when ALL criteria are met. Items not applicable to a term infant with a short stay may be documented as not applicable.

    • Thermoregulation: Normal axillary temperature maintained in an open crib in room-temperature clothing and bedding36.5 to 37.5 C
    • Feeding: All feeds taken by breast or bottle without cardiorespiratory compromise, or an established tube-feeding plan with equipment arranged and caregivers trained and competent
    • Growth: Sustained weight gain documented over several consecutive daysAbout 20 to 30 g/day may guide assessment but is not a hard threshold; no minimum discharge weight
    • Respiratory control: No clinically significant apnea, bradycardia, or desaturation during the required event-free observation periodCommonly 5 to 7 days after caffeine is stopped

      Longer observation may be needed for the lowest gestational ages.

    • Respiratory status: Room air, or stable low-flow home oxygen with target saturations met, home equipment delivered, and caregivers trained
    • Screening and immunization: Newborn metabolic screen, hearing screen, critical congenital heart disease screen when not otherwise evaluated by echocardiography, eligible retinopathy examinations, and age-appropriate immunizations completed or scheduled
    • Car safety seat observation completed for infants born before 37 weeks or with hypotonia or airway risk

      Use an appropriate car seat or car bed.

    • Caregiver and follow-up readiness: Caregiver competency documented for feeding, medications, equipment, safe sleep, infant CPR, and warning signs; primary care visit scheduled within a few days and indicated subspecialty and early-intervention referrals made
    • Stable respiratory support and follow-up: Stable on room air or fixed low-flow oxygen for several days without desaturation during feeds or sleep; home equipment delivered; pulmonology follow-up arranged and cardiology follow-up arranged when pulmonary hypertension is present
    • Tracheostomy and home ventilation readiness: For infants with tracheostomy and home ventilation, two trained caregivers, a home nursing plan, equipment, and an emergency plan are in place

    Continued-stay criteria

    Continued stay is medically necessary when discharge readiness has not been met and ANY qualifying condition is documented.

    • Respiratory support: Any positive-pressure support, or oxygen requiring frequent titration or not yet stable at a home-oxygen requirement
    • Apnea, bradycardia, or desaturation: Clinically significant events within the current event-free window, or ongoing caffeine therapy with events
    • Temperature instability: Unable to maintain normal temperature in an open crib
    • Feeding or fluid support: Not taking all feeds orally with adequate intake, or parenteral nutrition or intravenous fluids remain necessary when discharge with tube feeding is not feasible
    • Medication requiring inpatient care: Intravenous antimicrobial, anticonvulsant, vasoactive, or other medication cannot safely be given at home
    • Procedure or complication: Pending or recent surgery or procedure, or newly identified complication under active evaluation
    • Grade 2 or 3 BPD support: Grade 2 or 3 BPD remains on positive-pressure support
    • Pulmonary hypertension treatment: Pulmonary hypertension therapy is being initiated or titrated
    • Tracheostomy training: Home-ventilation caregiver training is not complete

    High-dose dexamethasone at 0.5 mg/kg/day or more for chronic lung disease is not recommended and does not meet the coverage criteria under this policy.

    A continued inpatient stay does not meet criteria when it is solely for stable low-flow oxygen, to reach a target weight or postmenstrual age, to complete testing that can occur the same day or as an outpatient, or because of social, placement, transportation, or caregiver-availability barriers. Observation of a well-appearing infant at 35 weeks or more without a clinical severity finding is also excluded.

    A stable low-flow oxygen requirement alone is not medically necessary for continued inpatient care when all other discharge-readiness criteria are met and home oxygen has been arranged. Home oxygen is an appropriate alternative, with outpatient follow-up and discharge planning.

    High-dose dexamethasone at 0.5 mg/kg/day or more for chronic lung disease is not medically necessary under this policy. Requests involving this dose require physician review.

    Continued hospitalization solely to reach a target weight or specific postmenstrual age is not medically necessary when the infant has met physiologic discharge criteria. Discharge decisions are based on physiologic competencies rather than a fixed weight or age target.

    A separate inpatient day solely to await a car-seat observation, hearing screen, or other test that can be completed the same day or arranged as an outpatient is not medically necessary. The test should be completed before discharge when feasible or scheduled outpatient.

    Days continued solely for social, placement, transportation, or caregiver-availability reasons after the infant is medically ready for discharge are not medically necessary. These circumstances are routed to physician review and discharge planning; days already authorized are not retroactively denied.

    Admission to a NICU or special care nursery solely to observe a well-appearing infant born at 35 weeks or more, without a clinical severity finding, is not medically necessary. Level I well-newborn or mother-baby care is appropriate.

    Diagnostic, Procedural, and Operational Coding

    ICD-10-CM: chronic perinatal lung diseaseICD-10
    P27.1Chronic perinatal lung disease
    P27.0Chronic perinatal lung disease
    P27.8Chronic perinatal lung disease
    P27.9Chronic perinatal lung disease
    J84.841Chronic perinatal lung disease
    ICD-10-CM: added pulmonary hypertension due to lung diseaseICD-10
    I27.23Pulmonary hypertension due to lung disease
    ICD-10-PCS: ventilation and tracheostomyICD-10
    5A09557Ventilation and tracheostomy
    5A0955AVentilation and tracheostomy
    5A1955ZVentilation and tracheostomy
    0B110F4Ventilation and tracheostomy
    0B113F4Ventilation and tracheostomy
    MS-DRG (FY2027 v44)Revenue
    003MS-DRG
    790MS-DRG
    791MS-DRG
    792MS-DRG
    Revenue codesRevenue
    0173Revenue code
    0174Revenue code
    0410Revenue code
    0250Revenue code
    0300Revenue code
    ICD-10-CM: chronic perinatal lung disease (v4.0)ICD-10
    P27.1chronic perinatal lung disease (v4.0)
    P27.0chronic perinatal lung disease (v4.0)
    P27.8chronic perinatal lung disease (v4.0)
    P27.9chronic perinatal lung disease (v4.0)
    J84.841chronic perinatal lung disease (v4.0)
    ICD-10-CM: added pulmonary hypertension due to lung diseaseICD-10
    I27.23added pulmonary hypertension due to lung disease
    ICD-10-PCS: ventilation and tracheostomyICD-10
    5A09557ventilation and tracheostomy
    5A0955Aventilation and tracheostomy
    5A1955Zventilation and tracheostomy
    0B110F4ventilation and tracheostomy
    0B113F4ventilation and tracheostomy
    MS-DRG (FY2027 v44)mixed
    003MS-DRG (FY2027 v44)
    790MS-DRG (FY2027 v44)
    791MS-DRG (FY2027 v44)
    792MS-DRG (FY2027 v44)
    Revenue codesRevenue
    0173Revenue codes
    0174Revenue codes
    0410Revenue codes
    0250Revenue codes
    0300Revenue codes
    FiO2 increase
    ThresholdAn increase in FiO2 of 0.20 or more.
    Clinical significanceA rising FiO2 at this level is an acute respiratory decompensation finding.
    Required responseImmediate bedside neonatologist evaluation and escalation of respiratory support are required; transfer to Level III or IV care if needed.
    BPD grade 1 respiratory support
    BPD classificationGrade 1 BPD.
    Respiratory supportNasal cannula at 2 L/min or less at 36 weeks PMA.
    Related classificationNo BPD means no respiratory support at 36 weeks PMA.
    BPD grade 2 respiratory support
    BPD classificationGrade 2 BPD.
    Respiratory supportNasal cannula above 2 L/min at 36 weeks PMA, or noninvasive positive airway pressure.
    Alternative supportGrade 2 also includes high-flow nasal cannula above 2 L/min or noninvasive positive pressure.
    BPD grade 3 respiratory support
    BPD classificationGrade 3 BPD.
    Respiratory supportInvasive mechanical ventilation at 36 weeks PMA.
    Severity contextGrade 3 BPD on invasive ventilation is an intensive-care criterion.
    High-dose dexamethasone
    Dose thresholdDexamethasone at 0.5 mg/kg/day or more.
    Policy positionHigh-dose dexamethasone for chronic lung disease is not recommended under this policy.
    Review pathwayRequests for high-dose dexamethasone are referred for physician review.
    Discharge temperature
    Temperature range36.5 to 37.5 C axillary temperature.
    Care settingThe temperature must be maintained in an open crib with room-temperature clothing and bedding.
    Discharge requirementNormal temperature maintained in an open crib is required for discharge readiness.
    Event-free observation
    Usual observation periodCommonly 5 to 7 days after caffeine is stopped.
    Extended observationLonger observation may be needed for infants born at the lowest gestational ages.
    Discharge standardNo clinically significant apnea, bradycardia, or desaturation may occur during the required event-free period.
    Brief mechanical ventilation
    Duration thresholdMechanical ventilation under 24 hours.
    Care contextBrief mechanical ventilation may occur while the infant is stabilizing or awaiting transfer.
    Level-of-care pathwayNasal CPAP, high-flow nasal cannula, or brief mechanical ventilation may support intermediate care when intensive-care criteria are not met.
    NICU intensive-care population
    Gestational-age criterionGestational age below 32 0/7 weeks.
    Birth-weight criterionBirth weight below 1500 g.
    Applicable phaseThese criteria apply during initial stabilization and the intensive phase and identify an AAP Level III population.
    Level I physiologic stability
    Gestational ageAt least 35 0/7 weeks.
    Physiologic requirementsNormal temperature in an open crib, breathing room air, and feeding orally.
    Care levelThis profile supports AAP Level I well-newborn or mother-baby care when no intensive or intermediate criterion is met.
    BPD severity assessment
    Assessment measureRespiratory support mode.
    Assessment timeAt 36 weeks postmenstrual age.
    Classification basisThe Jensen definition grades BPD by respiratory-support mode rather than oxygen exposure alone, regardless of supplemental oxygen use.

    Authorization and Documentation Requirements

    Prior Authorization

    Initial Inpatient Medical Necessity

    Approve inpatient NICU or special care nursery care for BPD when both conditions are met: at least one clinical severity finding and at least one required hospital-level service.

    • Clinical severity findings include qualifying prematurity with ongoing respiratory support or oxygen, grade 2 or 3 BPD requiring high-flow nasal cannula above 2 L/min, noninvasive positive pressure, or invasive ventilation; acute decompensation; or BPD-associated pulmonary hypertension on echocardiography.
    • Hospital-level services include positive-pressure respiratory support, oxygen requiring frequent titration, a low-dose systemic corticosteroid course after parental shared decision-making, pulmonary vasodilator initiation or titration with echocardiographic monitoring, or tracheostomy with initiation of chronic home ventilation and caregiver training.
    Documentation Required

    Concurrent Continued-Stay Review

    For each continued-stay period, document that discharge readiness has not been met and that at least one qualifying continued-stay condition remains present. Perform concurrent review every 24 to 72 hours during the intensive phase and at least every 7 days during stable convalescent growth, with daily attending documentation.

    • Qualifying conditions include ongoing positive-pressure support or oxygen requiring frequent titration; significant apnea, bradycardia, or desaturation or ongoing caffeine with events; inability to maintain temperature in an open crib; inadequate oral feeding or ongoing parenteral nutrition or IV fluids when tube-feeding discharge is not feasible; unsafe-to-administer-at-home medications; pending surgery, a newly identified complication, grade 2 or 3 BPD on positive pressure, pulmonary hypertension under treatment titration, or incomplete tracheostomy home-ventilation training.
    Documentation Required

    Document Growth and Maturity

    Submit the infant’s growth and maturity data for review.

    • Gestational age in completed weeks and days
    • Birth weight
    • Current postmenstrual age (PMA)
    • Current weight
    Documentation Required

    Document Respiratory Support

    Document the infant’s daily respiratory support and oxygenation targets.

    • Respiratory support mode and settings
    • FiO2
    • Target saturation range
    Documentation Required

    Document Feeding Status

    Document feeding progress and ongoing nutritional support.

    • Feeding route
    • Volume in mL/kg/day
    • Percentage taken orally
    • Parenteral nutrition status
    Documentation Required

    Document Thermoregulation

    Document the support required for thermoregulation.

    • Indicate whether the infant is in an incubator, under a radiant warmer, or in an open crib.
    Documentation Required

    Document Event History

    Provide the current event history and caffeine plan.

    • Apnea, bradycardia, and desaturation event log
    • Interventions required for each event
    • Caffeine stop date
    Documentation Required

    Document Clinical Treatment

    Document treatment details relevant to the medical-necessity criteria.

    • Medications
    • Vascular access devices
    • Relevant laboratory results
    • Relevant imaging results
    Documentation Required

    Document Level-of-Care Rationale

    Document the treating unit’s AAP level and why that level of care is required for the infant.

    • AAP level of the treating unit
    • Clinical rationale for requiring that level
    Documentation Required

    Document Discharge Planning

    Provide the discharge-readiness and transition-of-care record.

    • Discharge readiness checklist
    • Screening results
    • Caregiver training
    • Home equipment
    • Follow-up appointments
    Documentation Required

    Document BPD Grade

    At 36 weeks PMA, document the respiratory support mode and flow and the resulting BPD grade.

    • Respiratory support mode at 36 weeks PMA
    • Flow at 36 weeks PMA
    • Resulting BPD grade
    Documentation Required

    Document Pulmonary Hypertension Evaluation

    Document applicable echocardiographic screening for BPD-associated pulmonary hypertension.

    • Include the echocardiogram result when pulmonary hypertension is suspected, being evaluated, or under treatment.
    Documentation Required

    Document Corticosteroid Treatment

    For systemic corticosteroid treatment, document the complete course and shared decision-making with the parents.

    • Corticosteroid name and course
    • Dose
    • Parental discussion or shared decision-making
    Documentation Required

    Document Home Ventilation Readiness

    When applicable, document tracheostomy and readiness for chronic home ventilation.

    • Tracheostomy records
    • Home-ventilation training records
    • Caregiver training completion status

    Unsupported block type: denial_riskใ},{

    Denial Risk

    High-Dose Dexamethasone Requires Physician Review

    High-dose dexamethasone at 0.5 mg/kg/day or more does not meet criteria under this policy and requires physician review.

    • The request is not automatically denied; refer it for review by a licensed physician of the same or similar specialty.
    Denial Risk

    Nonclinical Weight or Age Target

    Do not extend inpatient care solely to reach a target weight or specific PMA when physiologic discharge criteria are met.

    • AAP discharge guidance is based on physiologic competencies rather than a fixed weight or age.
    • Refer requests relying on a nonclinical weight or age target for physician review and discharge planning.

    Unsupported block type: denial_risk

    Unsupported block type: denial_risk

    Unsupported block type: denial_risk

    Unsupported block type: prior_auth

    Unsupported block type: billing_rule

    Policy Background

    Bronchopulmonary dysplasia is a common chronic morbidity of very preterm birth. This policy uses the Jensen 2019 definition, which grades BPD according to the mode of respiratory support at 36 weeks postmenstrual age rather than oxygen exposure alone. Established BPD may be complicated by pulmonary hypertension, chronic ventilation, or tracheostomy, requiring coordinated respiratory, cardiac, discharge, and caregiver-readiness planning.

    Clinical Definitions

    BPD grade (Jensen 2019)
    Assessment timeBPD grade is determined at 36 weeks PMA.
    No BPDNo respiratory support.
    Grade 1Nasal cannula at 2 L/min or less.
    Grade 2Nasal cannula above 2 L/min or noninvasive positive airway pressure.
    Grade 3Invasive mechanical ventilation.
    BPD-associated pulmonary hypertension
    ConditionPulmonary hypertension in an infant with BPD.
    Diagnostic methodIdentified on echocardiography or catheterization.
    Clinical relevancePulmonary hypertension may affect the infant's level of care and discharge planning.
    Jensen definition of bronchopulmonary dysplasia
    Definition basisBPD severity is categorized according to the mode of respiratory support.
    Assessment timeRespiratory support is assessed at 36 weeks postmenstrual age.
    Oxygen useThe categorization applies regardless of supplemental oxygen use.